Phase III Clinical Trial to Evaluate the Efficacy of Bevacizumab with Tarceva for Non-Small Cell Lung Cancer after failure of First Line Chemotherapy
|Effective start/end date
|5/1/05 → 2/28/11
- GENENTECH, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.